Memphasys tech: Trial results prove it lifts the guys’ game in IVF
Reproductive technology developed by Memphasys (ASX:MEM) is proving to be a gamechanger…
Memphasys Limited. (ASX:MEM)
About Memphasys Limited.
Key Information
MEM In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 24/03/2025 | Price Sensitive PS Felix Trial Confirms Best-in-Class Performance | 245.58KB | 25K |
| 20/03/2025 | Price Sensitive PS Trading Halt | 266.8KB | 8.9K |
| 13/03/2025 | MEM secures R&D Tax Rebate loan | 223.01KB | 4.1K |
| 28/02/2025 | Price Sensitive PS Half Yearly Report and Accounts | 1.77MB | 452 |
| 28/02/2025 | Price Sensitive PS Extension of Convertible Notes | 173.72KB | 903 |
| 25/02/2025 | Investor Presentation Feb 25 | 4.33MB | 11K |
| 24/02/2025 | Price Sensitive PS Felix Data lock complete and regulatory submission commenced | 235.7KB | 4.2K |
| 17/02/2025 | Price Sensitive PS Leading Brazilian Andrology Clinic to test Felix System | 225.1KB | 3.0K |